Year: 2009
Type: article
Abstract: WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Midazolam is extensively metabolized and is eliminated in urine predominantly as conjugates of 1′‐hydroxymidazolam. • Midazolam is known to undergo N‐glucuronidationin vitroby UGT1A4. • In vitro1′‐hydroxymidazolam is O‐glucuronidated by UGT2B4 and UGT2B7, and N‐glucuronidated by UGT1A4. WHAT THIS STUDY ADDS • N‐glucuronide of midazolam has been quantified in human urine, indicating for the first time that this route of metabolism occursin vivo. • Metabolism of 4‐hydroxymidazolam has been compared with that of 1′‐hydroxymidazolamin vitro. • This study provides further evidence,in vitroandin vivo, of the importance of N‐glucuronidation in the metabolism of midazolam and its metabolites. AIMSMidazolam (MDZ) is a benzodiazepine used as a CYP3A4 probe in clinical andin vitrostudies. A glucuronide metabolite of MDZ has been identifiedin vitroin human liver microsome (HLM) incubations. The primary aim of this study was to understand thein vivorelevance of this pathway. METHODSAn authentic standard of N‐glucuronide was generated from microsomal incubations and isolated using solid‐phase extraction. The structure was confirmed using proton nuclear magnetic resonance (NMR) and1H‐13C long range correlation experiments. The metabolite was quantifiedin vivoin human urine samples. Enzyme kinetic behaviour of the pathway was investigated in HLM and recombinant UGT (rUGT) enzymes. Additionally, preliminary experiments were performed with 1′‐OH midazolam (1′‐OH MDZ) and 4‐OH‐midazolam (4‐OH MDZ) to investigate N‐glucuronidation. RESULTSNMR data confirmed conjugation of midazolam N‐glucuronide (MDZG) standard to be on the α‐nitrogen of the imidazole ring.In vivo, MDZG in the urine accounted for 1–2% of the administered dose.In vitroincubations confirmed UGT1A4 as the enzyme of interest. The pathway exhibited atypical kinetics and a substrate inhibitory cooperative binding model was applied to determineKm(46 µM, 64 µM),Vmax(445 pmol min−1 mg−1, 427 pmol min−1 mg−1) andKi(58 µM, 79 µM) in HLM and rUGT1A4, respectively. From incubations with HLM and rUGT enzymes, N‐glucuronidation of 1′‐OH MDZ and 4‐OH MDZ is also inferred. CONCLUSIONSA more complete picture of MDZ metabolism and the enzymes involved has been elucidated. Direct N‐glucuronidation of MDZ occursin vivo. Pharmacokinetic modelling using Simcyp™ illustrates an increased role for UGT1A4 under CYP3A inhibited conditions.
Authors: Ruth Hyland, Toby Osborne, Anthony Payne, Sarah Kempshall, Y. Raj Logan, Khaled Ezzeddine, Barry Jones
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W2063464585
